Göm menyn

Publications for Margareta Reis


Publications mentioned in social media 106 times*

Journal Articles

Emelie Wolgast, Ann Josefsson, Martin Josefsson, Caroline Lilliecreutz and Margareta Reis
  Drug use in pregnant women-a pilot study of the coherence between reported use of drugs and presence of drugs in plasma
  European Journal of Clinical Pharmacology, 2018, 74(4), 535-539.
   Fulltext  PDF  
 Web of Science® Times Cited: 2

Vanda Faria, Malin Gingnell, Johanna M. Hoppe, Olof Hjorth, Iman Alaie, Andreas Frick, Sara Hultberg, Kurt Wahlstedt, Jonas Engman, Kristoffer N. T. Mansson, Per Carlbring, Gerhard Andersson, Margareta Reis, Elna-Marie Larsson, Mats Fredrikson and Tomas Furmark
  Do You Believe It? Verbal Suggestions Influence the Clinical and Neural Effects of Escitalopram in Social Anxiety Disorder: A Randomized Trial
  EBioMedicine, 2017, 24, 179-188.
 Web of Science® Times Cited: 2

Carl Söderberg, Emma Wernvik, Andreas Tillmar, Olav Spigset, Robert Kronstrand, Margareta Reis, Anna K. Jonsson and Henrik Druid
  Antipsychotics - Postmortem fatal and non-fatal reference concentrations
  Forensic Science International, 2016, 266, 91-101.
 Web of Science® Times Cited: 4

Malin Gingnell, Andreas Frick, Jonas Engman, Iman Alaie, Johannes Bjorkstrand, Vanda Faria, Per Carlbring, Gerhard Andersson, Margareta Reis, Elna-Marie Larsson, Kurt Wahlstedt, Mats Fredrikson and Tomas Furmark
  Combining escitalopram and cognitive-behavioural therapy for social anxiety disorder: randomised controlled fMRI trial
  British Journal of Psychiatry, 2016, 209(3), 229-235.
 Web of Science® Times Cited: 7

Bengt Kallen and Margareta Reis
  Ongoing Pharmacological Management of Chronic Pain in Pregnancy
  Drugs, 2016, 76(9), 915-924.
 Web of Science® Times Cited: 6

Ann Zetterqvist, Patrik Aronsson, Staffan Hägg, Karin Kjellgren, Margareta Reis, Gunnar Tobin and Shirley Booth
  On the pedagogy of pharmacological communication: a study of final semester health science students
  BMC Medical Education, 2015, 15, .
   Fulltext  PDF  
 Web of Science® Times Cited: 2

Patrik Aronsson, Shirley Booth, Staffan Hägg, Karin Kjellgren, Ann Zetterqvist, Gunnar Tobin and Margareta Reis
  The understanding of core pharmacological concepts among health care students in their final semester
  BMC Medical Education, 2015, 15(1), .
   Fulltext  PDF  
 Web of Science® Times Cited: 2

Bengt Kallen and Margareta Reis
  Use of tramadol in early pregnancy and congenital malformation risk
  Reproductive Toxicology, 2015, 58, 246-251.
   Fulltext  PDF  
 Web of Science® Times Cited: 6

Anna K Jönsson, Carl Soderberg, Ketil Arne Espnes, Johan Ahlner, Anders Eriksson, Margareta Reis and Henrik Druid
  Sedative and hypnotic drugs-Fatal and non-fatal reference blood concentrations
  Forensic Science International, 2014, 236, 138-145.
   Fulltext  PDF  
 Web of Science® Times Cited: 9

Margareta Reis and Bengt Kallen
  Combined use of selective serotonin reuptake inhibitors and sedatives/hypnotics during pregnancy: risk of relatively severe congenital malformations or cardiac defects. A register study
  BMJ Open, 2013, 3(2), .
   Fulltext  PDF  
 Web of Science® Times Cited: 17

Margareta Reis, Patrik Aronsson, Shirley Booth, Staffan Hägg, Gunnar Tobin, Ann Zetterqvist and Karin Kjellgren
  Lättare för studenter att återge fakta än att dra egna slutsatser
  Läkartidningen, 2013, 110(48), 2156-2157.

Bengt Källén, Natalia Borg and Margareta Reis
  The Use of Central Nervous System Active Drugs During Pregnancy
  Pharmaceuticals, 2013, 6(10), 1221-1286.
   Fulltext  PDF  

Bengt Kallen and Margareta Reis
  Neonatal Complications After Maternal Concomitant Use of SSRI and Other Central Nervous System Active Drugs During the Second or Third Trimester of Pregnancy
  Journal of Clinical Psychopharmacology, 2012, 32(5), 608-614.
 Web of Science® Times Cited: 20

Margareta Reis and B Kallen
  Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data
  PSYCHOLOGICAL MEDICINE, 2010, 40(10), 1723-1733.
 Web of Science® Times Cited: 181

Margareta Reis, Ann-Charlotte Akerblad, Lisa Ekselius and Lars von Knorring
  Letter: Partial Compliance as Determined From Plasma Levels of Sertraline and Its Metabolite in Depressed Patients in Primary Care
  Journal of Clinical Psychopharmacology, 2010, 30(6), 746-748.
 Web of Science® Times Cited: 5

Margareta Reis, Trond Aamo, Olav Spigset and Johan Ahlner
  Serum Concentrations of Antidepressant Drugs in a Naturalistic Setting: Compilation Based on a Large Therapeutic Drug Monitoring Database
  THERAPEUTIC DRUG MONITORING, 2009, 31(1), 42-56.
 Web of Science® Times Cited: 69

Anna-Britta Lind, Margareta Reis, Finn Bengtsson, Michele Jonzier-Perey, Golay K. Powell, Johan Ahlner, P. Baumann and M.-L. Dahl
  Steady-state concentrations of mirtazapine, N-desmethylmirtazapine, 8-hydroxymirtazapine and their enantiomers in relation to cytochrome P450 2D6 genotype, age and smoking behaviour
  Clinical Pharmacokinetics, 2009, 48(1), 63-70.
 Web of Science® Times Cited: 27

Margareta Reis and B. Kallen
  Maternal use of antipsychotics in early pregnancy and delivery outcome.
  Journal of Clinical Psychopharmacology, 2008, 28(3), 279-288.
 Web of Science® Times Cited: 112

Maria Dolores Cherma Yeste, Margareta Reis, Staffan Hägg, Johan Ahlner and Finn Bengtsson
  Therapeutic Drug Monitoring of Ziprasidone in a Clinical Treatment Setting
  Therapeutic Drug Monitoring, 2008, 30(6), 682-688.
 Web of Science® Times Cited: 14

Margareta Reis, T. Aamo, Johan Ahlner and H. Druid
  Reference concentrations of antidepressants. A compilation of postmortem and therapeutic levels
  Journal of Analytical Toxicology, 2007, 31(5), 254-264.
 Web of Science® Times Cited: 45

Margareta Reis, Maria Dolores Cherma Yeste, Björn Carlsson and Finn Bengtsson
  Therapeutic Drug Monitoring of Escitalopram in an outpatient setting
  Therapeutic Drug Monitoring, 2007, 29(6), 758-766.
 Web of Science® Times Cited: 24

Margareta Reis, Fredrik Kugelberg, Björn Carlsson, Martin Josefsson and Bertil Wahldeck
  Stereokemi och läkemedelseffekter -ett försummat kunskapsområde
  Läkartidningen, 2006, 103, 1305-1311.

Margareta Reis, Jiri Prochazka, Ad Sitsen, Johan Ahlner and Finn Bengtsson
  Inter- and intraindividual pharmacokinetic variations of mirtazapine and its N-demethyl metabolite in patients treated for major depressive disorder: A 6-month therapeutic drug monitoring study
  Therapeutic Drug Monitoring, 2005, 27(4), 469-477.
 Web of Science® Times Cited: 22

Margareta Reis, Anna Åberg-Wistedt, Hans Ågren, Ann-Charlotte Åkerblad and Finn Bengtsson
  Compliance with SSRI medication during 6 months of treatment for major depression: an evaluation by determination of repeated serum drug concentrations
  Journal of Affective Disorders, 2004, 82(3), 443-446.
 Web of Science® Times Cited: 23

Margareta Reis, Anna Åberg-Wistedt, Hans Ågren, Peter Höglund, Ann-Charlotte Åkerblad and Finn Bengtsson
  Serum disposition of sertraline, N-desmethylsertraline and paroxetine: a pharmacokinetic evaluation of repeated drug concentration measurements during 6 months of treatment for major depression
  Human Psychopharmacology: Clinical and Experimental, 2004, 19(5), 283-291.
 Web of Science® Times Cited: 28

Margareta Reis, Jöns Lundmark and Finn Bengtsson
  Therapeutic drug monitoring of racemic citalopram: a 5-year experience in Sweden, 1992-1997
  Therapeutic Drug Monitoring, 2003, 25(2), 183-191.
 Web of Science® Times Cited: 42

Margareta Reis, Gunilla Olsson, Björn Carlsson, Jöns Lundmark, Marja-Liisa Dahl, Jan Wålinder, Johan Ahlner and Finn Bengtsson
  Serum levels of citalopram and its main metabolites in adolescent patients treated in a naturalistic clinical setting
  Journal of Clinical Psychopharmacology, 2002, 22(4), 406-413.
 Web of Science® Times Cited: 18

Elisabeth Skogh, Margareta Reis, Marja-Liisa Dahl, Jöns Lundmark and Finn Bengtsson
  Therapeutic drug monitoring data on olanzapine and its N-demethyl metabolite in the naturalistic clinical setting
  Therapeutic Drug Monitoring, 2002, 24(4), 518-526.
 Web of Science® Times Cited: 74

Margareta Reis, Jöns Lundmark, Henrik Björk and Finn Bengtsson
  Therapeutic drug monitoring of racemic venlafaxine and its main metabolites in an everyday clinical setting
  Therapeutic Drug Monitoring, 2002, 24(4), 545-553.
 Web of Science® Times Cited: 46

Björn Carlsson, Gunilla Olsson, Margareta Reis, Jan Wålinder, Conny Nordin, Jöns Lundmark, M. G. Scordo, M-L. Dahl, Finn Bengtsson and Johan Ahlner
  Enantioselective Analysis of Citalopram and Metabolites in Adolescents
  Therapeutic drug monitoring, 2001, 23(6), 658-664.
 Web of Science® Times Cited: 30

Jöns Lundmark, Margareta Reis and Finn Bengtsson
  Serum concentrations of fluoxetine in the clinical treatment setting
  Therapeutic Drug Monitoring, 2001, 23(2), 139-147.
 Web of Science® Times Cited: 39

Jöns Lundmark, Finn Bengtsson, Conny Nordin, Margareta Reis and Jan Wålinder
  Therapeutic drug monitoring of selective serotonin reuptake inhibitors influences clinical dosing strategies and reduces drug costs in depressed elderly patients
  Acta Psychiatrica Scandinavica, 2000, 101(5), 354-359.
 Web of Science® Times Cited: 74

Jöns Lundmark, Margareta Reis and Finn Bengtsson
  Therapeutic drug monitoring of sertraline: Variability factors as displayed in a clinical setting
  Therapeutic Drug Monitoring, 2000, 22(4), 446-454.
 Web of Science® Times Cited: 40

Conference Articles

Margareta Reis and B Kallen
  IMPACT OF IN UTERO EXPOSURE TO ANTIDEPRESSANTS ON THE FETUS in JOURNAL OF PSYCHOPHARMACOLOGY, vol 25, issue 8, pp A9-A9
  JOURNAL OF PSYCHOPHARMACOLOGY, 2011.


Margareta Reis, Lars von Knorring, Ann-Charlotte Akerblad and Lisa Ekselius
  Hidden Partial Non-Compliance with Antidepressants and its Effect on Treatment Response
  in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, vol 18, 2009.


Margareta Reis, A C Akerblad, L von Knorring and L Ekselius
  Hidden partial non-compliance with antidepressants and its effect on treatment response
  in EUROPEAN NEUROPSYCHOPHARMACOLOGY, vol 19, 2009.


Björn Carlsson, Gunilla Olsson, Margareta Reis, Jan Wålinder, Conny Nordin and Jöns Lundmark
  Adolescents on chronic oral dosing with racemic citalopram. Enantioselective analysis of citalopram and CYP2D6/CYP2C19 genotyping. 5 th Congress of the European Association for Clinical Pharmacology and Therapuetics, Odense, Denmark 12-15 september 2001
  Pharmacology and Toxicology,2001, 2001.


Ph.D. Theses

Margareta Reis
  Pharmacokinetics of antidepressant drugs: naturalistic and clinical trials
  2003.


* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.

 



Responsible for this page: Peter Berkesand
Last updated: 2010-08-30